01FDA-reviewed unapproved peptide identityKPV in New South Wales
KPV in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗02US research-market identityBPC-157 in New South Wales
BPC-157 in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗03US research-market identityTB-500 in New South Wales
TB-500 in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗04US research-market identityGHK-Cu in New South Wales
GHK-Cu in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗05US research-market identitySemax in New South Wales
Semax in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗06US research-market identityMelanotan II in New South Wales
Melanotan II in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗07US research-market identityMOTS-c in New South Wales
MOTS-c in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗08US research-market identity with a separate FDA-licensed medicine recordTesamorelin in New South Wales
Tesamorelin in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗09US research-market identity with a failed oral obesity program and no FDA-approved drugAOD-9604 in New South Wales
AOD-9604 in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗10US research-market identityIpamorelin in New South Wales
Ipamorelin in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗11US research-market identitySelank in New South Wales
Selank in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗12US research-market identity with a separate FDA-approved medicine recordPT-141 / Bremelanotide in New South Wales
PT-141 / Bremelanotide in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗13US research-market identityCJC-1295 no DAC in New South Wales
CJC-1295 no DAC in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗14US research-market identityCJC-1295 DAC in New South Wales
CJC-1295 DAC in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗15Investigational clinical programRetatrutide in New South Wales
Retatrutide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗16China-approved medicine and active clinical programMazdutide in New South Wales
Mazdutide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗17China-approved medicine and active development programEcnoglutide in New South Wales
Ecnoglutide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗18Investigational clinical programEnicepatide in New South Wales
Enicepatide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗19Investigational clinical programEloralintide in New South Wales
Eloralintide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗20Investigational clinical programCagrilintide in New South Wales
Cagrilintide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗21Investigational clinical programPetrelintide in New South Wales
Petrelintide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗22Investigational clinical programCagriSema in New South Wales
CagriSema in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗23Investigational clinical programMariTide in New South Wales
MariTide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗24Investigational clinical programSurvodutide in New South Wales
Survodutide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗25Investigational clinical programVK2735 in New South Wales
VK2735 in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗26Investigational clinical programPemvidutide in New South Wales
Pemvidutide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗27Investigational clinical programAmycretin / Zenagamtide in New South Wales
Amycretin / Zenagamtide in New South Wales refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗28US FDA medicine referenceTirzepatide in New South Wales
Tirzepatide in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗29FDA-approved US medicine with country-specific status elsewhereOrforglipron / Foundayo in New South Wales
Orforglipron / Foundayo in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗30Product-specific approved medicine records in multiple jurisdictionsSemaglutide in New South Wales
Semaglutide in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗31FDA-flagged unapproved research-market peptide identityDSIP / Emideltide in New South Wales
DSIP / Emideltide in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗32US research-market identityIGF-1 LR3 in New South Wales
IGF-1 LR3 in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗33US research-market identityKisspeptin-10 / KP-10 in New South Wales
Kisspeptin-10 / KP-10 in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗34US research-market identity separated from SCENESSEMelanotan I in New South Wales
Melanotan I in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗35US research-market non-peptide coenzyme identityNAD+ in New South Wales
NAD+ in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗36US research-market identity with a withdrawn historical medicine recordSermorelin in New South Wales
Sermorelin in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗37No FDA-approved US product; exact foreign prescription products existThymosin Alpha-1 in New South Wales
Thymosin Alpha-1 in New South Wales begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗38FDA-approved US medicine with a withdrawn EU applicationEGRIFTA WR in New South Wales
EGRIFTA WR in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗39Product-specific FDA and EU medicine recordsLiraglutide in New South Wales
Liraglutide in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗40Product-specific FDA and EU medicine recordsSCENESSE in New South Wales
SCENESSE in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗41Product-specific FDA-approved US medicine recordVYLEESI in New South Wales
VYLEESI in New South Wales begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving New South Wales, open Register of Pharmacies from Pharmacy Council of New South Wales and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.
Official jurisdiction routeRegister of PharmaciesPharmacy Council of New South Wales ↗